Table A4. Government Performance and Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures
| GPRA Goals |
Baseline |
Actual Performance |
Long-Term Goal |
|---|
| 2002 |
2007 |
2008 |
2010 |
|---|
| Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15 to 44 years of age) |
197,000 | 146,000 | 104,000 | 168,000 |
| a. Prevalence of Chlamydia in high-risk women ≤25 years* |
10.1% | 13.2% | 12.8% | 15.1% |
| b. Prevalence of Chlamydia in women ≤25 years in family planning clinics* |
5.6% | 6.9% | 7.4% | 7.4% |
| c. Incidence of Gonorrhea/100,000 population in women 15–44 years of age |
278.0 | 291.0 | 285.0 | 296 |
| Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population) |
2.4 | 3.8 | 4.5 | 2.2 |
| a. Incidence of P&S Syphilis/100,000 population—men |
3.8 | 6.6 | 7.6 | 7.2 |
| b. Incidence of P&S Syphilis/100,000 population—women |
1.1 | 1.1 | 1.5 | 1.2 |
| c. Incidence of Congenital Syphilis/100,000 live births |
10.2 | 10.1 | 10.1 | 9.4 |
| d. Black:white rate ratio of P&S Syphilis |
8:1 | 7:1 | 8:1 | 6.7:1 |
| GPRA Goals |
Data Source |
|---|
| 1 |
National Disease and Therapeutic Index (IMS Health). |
| 1–a |
National Job Training Program. |
| 1–b |
Regional Infertility Prevention Projects (IPP), STD Surveillance System (STDSS), NCHHSTP, CDC. |
| 1–c |
STD Surveillance System (STDSS), NCHHSTP, CDC. |
| 2 |
STD Surveillance System (STDSS), NCHHSTP, CDC. |
| 2–a |
STD Surveillance System (STDSS), NCHHSTP, CDC. |
| 2–b |
STD Surveillance System (STDSS), NCHHSTP, CDC. |
| 2–c |
STD Surveillance System (STDSS), NCHHSTP, CDC. |
| 2–d |
STD Surveillance System (STDSS), NCHHSTP, CDC. |
* Median state-specific chlamydia prevalence/positivity.
